Search results
Showing 7231 to 7245 of 7675 results
This guidance has been updated and replaced by NICE interventional procedures guidance 782.
This evidence summary has been updated and replaced by NICE guideline 115.
This evidence summary has been updated and replaced by NICE antimicrobial health technology evaluation guidance on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.
Preventing recurrence of Clostridium difficile infection: bezlotoxumab (ES13)
This advice has been updated and replaced by NICE guideline NG199.
Nivolumab for adjuvant treatment of resected non-small-cell lung cancer [ID4053]
In development [GID-TA10935] Expected publication date: TBC
February 2024: We have temporarily withdrawn this quality standard due to ongoing updates to the NICE guideline on sepsis, which underpins the quality statements. See the guidance in development page and guideline in development page for progress on these updates.
For any queries, please contact qualitystandards@nice.org.ukIn development [GID-TA10800] Expected publication date: TBC
Discontinued [GID-IPG10142]
May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. See our guidance on treating severe asthma and our guideline on managing COVID-19.
Palforzia for treating peanut allergy in children aged 1 to 3 [ID6144]
In development [GID-TA11070] Expected publication date: TBC
This interim methods and process guide for the proportionate approach to technology appraisals has been incorporated into NICE health technology evaluations: the manual.
This guidance has been updated and replaced by NICE technology appraisal guidance 970 and NICE technology appraisal guidance 974.
This guidance has been updated and replaced by NICE technology appraisal guidance 975.
Nivolumab with ipilimumab for untreated unresectable stage 3 non-small-cell lung cancer [ID6248]
In development [GID-TA11253] Expected publication date: TBC
In development [GID-TA11455] Expected publication date: TBC